Pharma Now Podcast Features Dr. Paul Faulder, CEO & Co-Founder of Elixir Software, On Revolutionizing Pharma R&D with iTraX
Elixir Software’s Dr. Paul Faulder shares how iTraX is transforming pharma R&D collaboration and accelerating innovation.
Pharma Now has launched a compelling new podcast episode featuring Dr. Paul Faulder, CEO and Co-Founder of Elixir Software, who unveils how his journey through AstraZeneca, GSK, and Amgen inspired the creation of iTraX, a next-generation platform redefining how global pharma teams collaborate in R&D.
In this episode, Dr. Paul discusses how fragmented systems and spreadsheets still hold back drug discovery, and how iTraX is changing that. Acting as an “operating system for R&D,” the platform unifies teams, streamlines workflows, and brings real-time visibility across global research networks. The result: fewer delays, smarter decisions, and faster breakthroughs that can reach patients sooner.
Dr. Paul also shares leadership lessons on building agile, vision-driven teams and why empowering scientists with modern tools is key to innovation.
“Dr. Faulder’s work with iTraX reflects the kind of digital innovation that’s redefining how pharma accelerates research and discovery,” said Mr. Ravindra Warang, Director & Editor-in-Chief, Pharma Now.
🎧 Discover how iTraX is reshaping the future of drug discovery. Listen to the full episode now on Voices of Pharma.
Reporting on the science, business and regulation shaping the pharmaceutical industry.
Altro da Pharma News
Tutti gli articoli →
Medicus Pharma presenta all’FDA il protocollo di fase 2b/3 per Teverelix
Fresenius Kabi Riceve una Lettera di Richiamo dalla FDA dopo Fallimenti nelle Indagini sul Processo Asettico presso lo Stabilimento di Melrose Park
Discussion